中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy 期刊论文
CHINESE MEDICAL JOURNAL, 2016, 卷号: 129
-
收藏  |  浏览/下载：26/0  |  提交时间：2020/10/26
PLATINUM-BASED CHEMOTHERAPY  CELL LUNG-CANCER  III COLON-CANCER  THYMIDYLATE SYNTHASE  ADJUVANT CHEMOTHERAPY  PREDICTIVE-VALUE  GASTRIC-CANCER  LINK REPAIR  ERCC1  EXPRESSION  Colorectal Cancer  Excision Repair Cross-complementation Group 1  Prognosis  
Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials 期刊论文
CHINESE MEDICAL JOURNAL, 2014, 卷号: 127
-
收藏  |  浏览/下载：27/0  |  提交时间：2020/10/26
PHASE-II TRIAL  SUPPORTIVE CARE  1ST-LINE TREATMENT  PLUS CISPLATIN  FOLINIC ACID  5-FLUOROURACIL  LEUCOVORIN  ADENOCARCINOMA  FLUOROURACIL  CARCINOMA  irinotecan  gastric cancer  meta-analysis